Skip to main content
. 2021 Feb 24;320(5):G700–G711. doi: 10.1152/ajpgi.00426.2020

Table 2.

Comparison between two groups with or without improvement of dyspeptic symptom after 2-wk treatment

No Improvement (n = 16) Improvement(n = 20) P Value
Characteristics
 Age, yr 43.2 ± 3.7 44.4 ± 3.8 0.831
 BMI, kg/m2 21.3 ± 0.5 22.2 ± 0.7 0.748
 Sex, female % 12 (75.0) 13 (65.0) 0.495
 Duration, mo 18.0 (10.0, 48.0) 12.0 (10.0, 48.0) 0.330
 FD subtype (PDS/EPS/Overlap) 10/1/5 13/0/7 0.479
 Treatment (taVNS %) 5 (31.3) 13 (65.0) 0.092
Autonomic function
 LF/HF (fasting) 3.73 ± 0.69 2.51 ± 0.37 0.105
 LF/HF (fed) 5.27 ± 0.86 3.24 ± 0.47 0.033
 HF (fasting) 0.28 ± 0.04 0.35 ± 0.04 0.231
 HF (fed) 0.21 ± 0.03 0.29 ± 0.03 0.094
Gastric pace-making activity
 %NSW (fasting) 67.1 ± 4.6 70.3 ± 2.5 0.513
 %NSW (fed) 51.6 ± 3.7 64.3 ± 3.3 0.018
Psychological state
 Anxiety score 8.0 (2.0, 14.0) 5.0 (1.0, 11.0) 0.028
 Depression score 3.0 (0.0, 8.0) 2.0 (0.0, 8.0) 0.096

BMI, body mass index; HF, high frequency; LF/HF, low frequency/high frequency; %NSW, percentage of normal gastric slow waves.